EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 11 rujna 2024. Database contains 4821 unique substances/entries.
Filter the list
|
-
|
26766-27-8
|
Acute Tox. 4 |
|||
|
432-270-4
|
221354-37-6
|
Repr. 2; STOT RE 2 |
|||
|
620-368-1
|
1031-47-6
|
Acute Tox. 1; Acute Tox. 2 |
|||
|
-
|
-
|
Pyr. Liq. 1; Skin Corr. 1B |
|||
|
259-537-6
|
55219-65-3
|
Repr. 1B; Lact.; Acute Tox. 4 |
|||
|
256-103-8
|
43121-43-3
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
200-875-0
|
75-50-3
|
Flam. Gas 1; Press. Gas; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
200-875-0
|
75-50-3
|
Flam. Liq. 1; Acute Tox. 4; Skin Corr. 1B |
|||
|
218-962-7
|
2303-17-5
|
Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
|||
|
BASIC YELLOW 105; C.I. BASIC YELLOW 105
|
405-860-4
|
121315-16-0
|
Skin Sens. 1 |
||
|
405-060-5
|
118712-89-3
|
Skin Irrit. 2 |
|||
|
443-150-6
|
101226-85-1
|
Flam. Liq. 3 |
|||
|
250-517-2
|
31218-83-4
|
Acute Tox. 3 |
|||
|
205-860-2
|
156-60-5
|
Flam. Liq. 2; Acute Tox. 4 |
|||
|
238-009-9
|
14166-21-3
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
SQ 27,616
|
416-020-1
|
96314-26-0
|
Repr. 2; Skin Sens. 1 |
||
|
SQ28,646
|
419-160-1
|
90657-55-9
|
Repr. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 |
||
|
231-186-3
|
7443-52-9
|
Acute Tox. 4 |
|||
|
DHP OPT
|
445-770-2
|
42031-28-7
|
Eye Dam. 1 |
||
|
229-977-3
|
6876-12-6
|
Flam. Liq. 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
AMINODIOXEPAN
|
419-050-3
|
79944-37-9
|
Skin Sens. 1 |
||
|
FC4010
|
417-290-3
|
147086-81-5
|
Acute Tox. 4 |
||
|
618-075-9
|
87820-88-0
|
Carc. 2; Acute Tox. 4 |
|||
|
204-854-7
|
127-65-1
|
Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1 |
|||
|
211-986-9
|
731-27-1
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||